Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

Mutational Analysis of p53 gene and dietary risk factors: p53 gene for developing targeted pharmaceutical products and dietary approaches to treat endometrial carcinoma

-15% su kodu: ENG15
43,93 
Įprasta kaina: 51,68 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
43,93 
Įprasta kaina: 51,68 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 51.6800 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 10,00 

Knygos aprašymas

Endometrial carcinoma is one of the most common malignancies in the female genital tract and poses serious health hazards. The gene P53 safeguards cell integrity however; a mutation in this gene increases the lifeline of the cells which are programmed for cell death. This particular gene participates in many human cancers including endometrial, ovarian and tubal carcinomas. In this study we screened exon 5 of p53 gene to find out whether this exon is a hotspot for mutations or not. We evaluated (n=45) samples of endometrial carcinoma and (n=45) controls from a local population. However, we were unable to find any nucleotide alteration in exon 5. It appears, therefore, exon 5 of p53 is not a hot spot for mutation in local population based on recent our findings.

Informacija

Autorius: Nasir Ali, Umar Bacha, Javed Muhammad,
Leidėjas: LAP LAMBERT Academic Publishing
Išleidimo metai: 2013
Knygos puslapių skaičius: 52
ISBN-10: 3848499525
ISBN-13: 9783848499526
Formatas: 220 x 150 x 4 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Mutational Analysis of p53 gene and dietary risk factors: p53 gene for developing targeted pharmaceutical products and dietary approaches to treat endometrial carcinoma“

Būtina įvertinti prekę

Goodreads reviews for „Mutational Analysis of p53 gene and dietary risk factors: p53 gene for developing targeted pharmaceutical products and dietary approaches to treat endometrial carcinoma“